Cypress Biopharma, Inc.
Cary, NC
- UEI
- NEHSZ3G3DKA9
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 15100 Weston Pkwy STE 101, Cary, NC 27513, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Leveraging the highly active metabolite of pioglitazone as a scaffold for a novel non-immunosuppressive therapy for… | National Institute of Diabetes and Digestive and Kidney Diseases | $611,572 |
Quick answers
What is Cypress Biopharma, Inc.'s UEI?
Cypress Biopharma, Inc.'s Unique Entity ID (UEI) in SAM.gov is NEHSZ3G3DKA9.
Where is Cypress Biopharma, Inc. located?
Cypress Biopharma, Inc.'s physical address in SAM.gov is 15100 Weston Pkwy STE 101, Cary, NC 27513, USA.
Is Cypress Biopharma, Inc. registered in SAM.gov?
Yes. Cypress Biopharma, Inc.'s SAM.gov registration is active through June 18, 2027.
What is Cypress Biopharma, Inc.'s most recent federal award?
Cypress Biopharma, Inc.'s most recent federal grant award is Leveraging the highly active metabolite of pioglitazone as a scaffold for a novel non-immunosuppressive therapy for… (R41DK146563), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 15, 2025.
On GovTribe
See Cypress Biopharma, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors